Everence Capital Management Inc Repligen Corp Transaction History
Everence Capital Management Inc
- $1.54 Billion
- Q4 2024
A detailed history of Everence Capital Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Everence Capital Management Inc holds 2,040 shares of RGEN stock, worth $327,440. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,040Holding current value
$327,440% of portfolio
0.02%Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
489Shares Held
54.2MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.21 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$1.03 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$810 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$261 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$228 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.91B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....